Seyfarth and Chambers Release Third Healthcare M&A Guide (USA Chapter)

Seyfarth’s Health Care, Life Sciences & Pharmaceuticals group is pleased to have once again partnered with Chambers to publish our latest contribution to their Healthcare M&A Guide—marking the third consecutive year of this collaboration. Our comprehensive overview offers a timely and practical analysis of the evolving legal, regulatory, and transactional landscape shaping health care mergers and acquisitions throughout the United States.

This year’s chapter reflects continued market shifts and heightened regulatory scrutiny, providing valuable insights for legal professionals, investors, and industry stakeholders navigating complex health care transactions. Drawing on the experience of Seyfarth’s multidisciplinary team, we explore both foundational concepts and emerging developments influencing deal activity across the sector.

Key topics covered include:

• Market trends and deal dynamics in health care M&A, including start-up formation, early-stage financing, and venture capital structures
• Liquidity pathways such as IPOs, private sales, hybrid strategies, and spin-offs/strategic realignments
• Transaction structures, valuation considerations, and acquisitions of public health care companies (including tender offers and mergers)
• Evolving regulatory landscape, including antitrust enforcement, state transaction review laws, and foreign investment considerations
• Data privacy, compliance, and diligence issues unique to the health care sector, along with disclosure, governance, and directors’ duties

Click here to access the publication. Please feel free to also reach out to Madeline Perkovich with any questions or feedback.